E-LIB Suche - Ergebnisse für: Xu, Binghe

1

Practice guideline on ovarian tissue cryopreservation and t..:

Ruan, Xiangyan ; Xu, Che ; Huang, Hefeng...
Maturitas. 182 (2024) - p. 107922 , 2024

Link: https://doi.org/10.1016/..

2

Poly (adenosine diphosphate‐ribose) polymerase inhibitors i..:

Yuan, Peng ; Ma, Nan ; Xu, Binghe
Medicinal Research Reviews. , 2024

Link: https://doi.org/10.1002/..

3

Metronomic chemotherapy plus anti-PD-1 in metastatic breast..:

Mo, Hongnan ; Yu, Yongpei ; Sun, Xiaoying...
Nature Medicine. , 2024

Link: https://doi.org/10.1038/..

4

Trastuzumab deruxtecan versus treatment of physician's choi..:

Yamashita, Toshinari ; Sohn, Joo Hyuk ; Tokunaga, Eriko...
Breast Cancer. , 2024

Link: https://doi.org/10.1007/..

5

TROPION-Breast01: Datopotamab deruxtecan vs chemotherapy in..:

Bardia, Aditya ; Jhaveri, Komal ; Kalinsky, Kevin...
Future Oncology. 20 (2024) 8 - p. 423-436 , 2024

Link: https://doi.org/10.2217/..

6

Adjuvant treatment strategy evolution and risk stratificati..:

Fan, Ying ; Ji, Danyang ; Jiang, Mingxia...
The Oncologist. , 2024

Link: https://doi.org/10.1093/..

7

Trastuzumab deruxtecan versus trastuzumab emtansine in Asia..:

Iwata, Hiroji ; Xu, Binghe ; Kim, Sung‐Bae...
Cancer Science. , 2024

Link: https://doi.org/10.1111/..

8

Impact of HER2‐low expression on the efficacy of endocrine ..:

Wu, Yun ; Mo, Hongnan ; Xu, Hangcheng...
Thoracic Cancer. 15 (2024) 12 - p. 965-973 , 2024

Link: https://doi.org/10.1111/..

9

Spotlight on ideal target antigens and resistance in antibo..:

Jiang, Mingxia ; Li, Qiao ; Xu, Binghe
Drug Resistance Updates. 75 (2024) - p. 101086 , 2024

Link: https://doi.org/10.1016/..

10

The anti-PD-L1/CTLA-4 bispecific antibody KN046 in combinat..:

Li, Qiao ; Liu, Jiaxuan ; Zhang, Qingyuan...
Nature Communications. 15 (2024) 1 - p. , 2024

Link: https://doi.org/10.1038/..

11

First-In-Human Phase I Study of Tinengotinib (TT-00420), a ..:

Piha-Paul, Sarina A ; Xu, Binghe ; Dumbrava, Ecaterina E...
The Oncologist. 29 (2024) 4 - p. e514-e525 , 2024

Link: https://doi.org/10.1093/..

12

Prognostic value and relapse pattern of HER2‐low in hormone..:

Wei, Tong ; Kang, Yikun ; Wang, Xue...
Thoracic Cancer. 15 (2024) 7 - p. 550-558 , 2024

Link: https://doi.org/10.1111/..

13

Disitamab vedotin, a HER2‐directed antibody‐drug conjugate,..:

Wang, Jiayu ; Liu, Yunjiang ; Zhang, Qingyuan...
Cancer Communications. , 2024

Link: https://doi.org/10.1002/..

14

New insights into HER2-low breast cancer brain metastasis: ..:

Xu, Hangcheng ; Wang, Yan ; Li, Li...
The Breast. 73 (2024) - p. 103669 , 2024

Link: https://doi.org/10.1016/..

15

HER2-targeting antibody drug conjugate FS-1502 in HER2-expr..:

Li, Qiao ; Cheng, Ying ; Tong, Zhongsheng...
Nature Communications. 15 (2024) 1 - p. , 2024

Link: https://doi.org/10.1038/..